MediciNova
MNOV
#9526
Rank
HK$0.57 B
Marketcap
HK$11.75
Share price
-3.21%
Change (1 day)
-34.34%
Change (1 year)

EPS for MediciNova (MNOV)

EPS in 2025 (TTM): -HK$1.87

According to MediciNova's latest financial reports the company's current EPS (TTM) is -HK$1.87. In 2024 the company made an earnings per share (EPS) of -HK$1.79 a decrease over its 2023 EPS that were of -HK$1.32.

EPS history for MediciNova from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.874.68%
2024-HK$1.7935.29%
2023-HK$1.32-41.38%
2022-HK$2.2638.1%
2021-HK$1.63-32.26%
2020-HK$2.413.33%
2019-HK$2.33-16.67%
2018-HK$2.8012.5%
2017-HK$2.49-3.03%
2016-HK$2.57-0%
2015-HK$2.57-13.16%
2014-HK$2.96100%
2013-HK$1.48-71.21%
2012-HK$5.13-45%
2011-HK$9.34-26.38%
2010-HK$12.68-2.98%
2009-HK$13.07-7.69%
2008-HK$14.16-56.25%
2007-HK$32.3718.18%
2006-HK$27.3922.22%
2005-HK$22.41-99.82%
2004-HK$12,3881182.05%
2003-HK$966.30-10.4%
2002-HK$1,078286.13%
2001-HK$279.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
HK$159.64-8,649.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$34.16 1,729.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.83-1,644.04%๐Ÿ‡ซ๐Ÿ‡ท France
Alkermes
ALKS
HK$16.11-962.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$4.90-362.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$57.26-3,166.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland